Chidimma Ruth Chukwunwejim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Chidimma Ruth Chukwunwejim has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Kingsley Chukwuebuka Agu
Nnamdi Azikiwe University, Awka, Nigeria, Nigeria
2 shared publications - Nwasoluchukwu Obidi
Department of Parasitology, Nnamdi Azikiwe University, Awka, Nigeria, Nigeria
2 shared publications - Nzube Ekpunobi
Department of Pharmaceutical microbiology and Biotechnology, Nnamdi Azikiwe University, Awka, Nigeria, Nigeria
2 shared publications - Amarachi Keziah Ezeike1 shared publication
- Angus Nnamdi Oli
Department of Pharmaceutical Microbiology and Biotechnology, Faculty of Pharmaceutical Sciences, Nnamdi Azikiwe University, Awka, Nigeria
1 shared publication - Aswin Rafif Khairullah
National Research and Innovation Agency
1 shared publication
Latest Publications
- Open Access
- 27 January 2026
- Published by Springer Nature in Malaria Journal
- Vol. 25 (1)
Urban evolution of insecticide resistance and susceptibility patterns of Anopheles coluzzii in Southeastern Nigeria: implications for malaria vector control
Insecticide resistance among malaria vectors remains a critical obstacle to effective vector control and malaria elimination across sub-Saharan Africa. Thi
- 27 January 2026
- Published by Springer Nature in Malaria Journal
- Vol. 25 (1)
Open AccessUrban evolution of insecticide resistance and susceptibility patterns of Anopheles coluzzii in Southeastern Nigeria: implications for malaria vector control
Insecticide resistance among malaria vectors remains a critical obstacle to effective vector control and malaria elimination across sub-Saharan Africa. Thi
- Open Access
- 4 September 2025
- Published by MDPI AG in Preprints.org
Prevalence of Multidrug-Resistant Escherichia coli O157:H7 from Live Bird Markets in Lagos, Nigeria
Escherichia coli (E. coli), a gram-negative bacterium, is a major concern for human and animal health. While most E. coli strains are commensal, some can become dangerous pathogens causing intestinal and systemic illnesses. Poultry meat is a potential source of infection; as resistant E. coli can be transmitted to humans through the food chain. This study aimed to determine the prevalence and antibiotic resistance patterns of E. coli O157:H7 in poultry feces from a live bird market in Lagos, Nigeria.Samples were enriched in TSB (9 mL) at 37 °C for 18–24 h, plated onto EMB and SMAC agar, and presumptive E. coli O157 isolates (non-sorbitol fermenters) were confirmed by latex agglutination, following the manufacturer’s instructions. Antimicrobial susceptibility testing was performed on confirmed E. coli O157 isolates using the Kirby-Bauer disc diffusion method.A total of 180 poultry fecal samples were analyzed. Out of these, 105 (58.33%) were identified as Escherichia coli isolates. The isolation process further revealed that 74 (41.11%) of the isolates were non-sorbitol fermenters, and 26 (14.44%) were confirmed as Escherichia coli O157:H7 using the latex agglutination test. The isolates showed high resistance to most of the tested antibiotics.The findings indicate a high prevalence and a high level of multidrug resistance in E. coli O157:H7 from indigenous chickens in Lagos' live bird markets. The presence of these pathogenic and resistant organisms poses a significant public health risk to individuals with direct contact with the birds and to consumers in Nigeria.
- 4 September 2025
- Published by MDPI AG in Preprints.org
Open AccessPrevalence of Multidrug-Resistant Escherichia coli O157:H7 from Live Bird Markets in Lagos, Nigeria
Escherichia coli (E. coli), a gram-negative bacterium, is a major concern for human and animal health. While most E. coli strains are commensal, some can become dangerous pathogens causing intestinal and systemic illnesses. Poultry meat is a potential source of infection; as resistant E. coli can be transmitted to humans through the food chain. This study aimed to determine the prevalence and antibiotic resistance patterns of E. coli O157:H7 in poultry feces from a live bird market in Lagos, Nigeria.Samples were enriched in TSB (9 mL) at 37 °C for 18–24 h, plated onto EMB and SMAC agar, and presumptive E. coli O157 isolates (non-sorbitol fermenters) were confirmed by latex agglutination, following the manufacturer’s instructions. Antimicrobial susceptibility testing was performed on confirmed E. coli O157 isolates using the Kirby-Bauer disc diffusion method.A total of 180 poultry fecal samples were analyzed. Out of these, 105 (58.33%) were identified as Escherichia coli isolates. The isolation process further revealed that 74 (41.11%) of the isolates were non-sorbitol fermenters, and 26 (14.44%) were confirmed as Escherichia coli O157:H7 using the latex agglutination test. The isolates showed high resistance to most of the tested antibiotics.The findings indicate a high prevalence and a high level of multidrug resistance in E. coli O157:H7 from indigenous chickens in Lagos' live bird markets. The presence of these pathogenic and resistant organisms poses a significant public health risk to individuals with direct contact with the birds and to consumers in Nigeria.
- Open Access
- 2 September 2025
- Published by Agricultural Research Communication Center in Asian Journal of Dairy and Food Research
- No. Of
High Frequency of Antibiotic-resistant Enterobacterales Contaminating Chicken Viscera in Nigeria: A Trigger for Foodborne Disease Outbreak
Background: Most of the Enterobacterales strains are non-pathogenic; however, there is increasing concern that some antibiotic-resistant strains of Shigella spp., E. coli, Klebsiella spp. and Salmonella spp. could spread from animals and their by-products to humans and cause different diseases. This study aimed to isolate, characterize and assess the antimicrobial resistance profiles of clinically important Enterobacterales isolated from chicken viscera samples in Nigeria. Methods: A total of 200 chicken viscera (intestine, gizzard, liver and crop) samples obtained from various poultry slaughterhouse outlets were analyzed using standard microbiological procedures. Using the disc diffusion technique, the detected Enterobacterales isolates were tested for antibiotic susceptibility. Result: Results showed that Salmonella spp., E. coli, Klebsiella spp. and Shigella spp. were members of the Enterobacterales recovered from the chicken viscera samples with frequency of 88 (44%), 72 (36%), 60 (30%) and 32 (16%) respectively. Additionally, the highest frequency of Enterobacterales isolation was from chicken intestine with a frequency of 92/252 (36.5%). Generally, all the recovered Enterobacterales were resistant (100%) to tetracycline and erythromycin, except for Klebsiella spp in which 16.7% resistance frequency was observed. Resistances were also observed with ampicillin (37.5%-100%), gentamicin (34.4%-66.7%) and ciprofloxacin (12.5%-83.3%). The average multiple antibiotic resistance index (MARI) value of the recovered isolates in this study was 0.7. This study has shown that chicken viscera parts are contaminated by multidrug-resistant (MDR) Enterobacterales such as Shigella spp., E. coli, Klebsiella spp. and Salmonella spp.
- 2 September 2025
- Published by Agricultural Research Communication Center in Asian Journal of Dairy and Food Research
- No. Of
Open AccessHigh Frequency of Antibiotic-resistant Enterobacterales Contaminating Chicken Viscera in Nigeria: A Trigger for Foodborne Disease Outbreak
Background: Most of the Enterobacterales strains are non-pathogenic; however, there is increasing concern that some antibiotic-resistant strains of Shigella spp., E. coli, Klebsiella spp. and Salmonella spp. could spread from animals and their by-products to humans and cause different diseases. This study aimed to isolate, characterize and assess the antimicrobial resistance profiles of clinically important Enterobacterales isolated from chicken viscera samples in Nigeria. Methods: A total of 200 chicken viscera (intestine, gizzard, liver and crop) samples obtained from various poultry slaughterhouse outlets were analyzed using standard microbiological procedures. Using the disc diffusion technique, the detected Enterobacterales isolates were tested for antibiotic susceptibility. Result: Results showed that Salmonella spp., E. coli, Klebsiella spp. and Shigella spp. were members of the Enterobacterales recovered from the chicken viscera samples with frequency of 88 (44%), 72 (36%), 60 (30%) and 32 (16%) respectively. Additionally, the highest frequency of Enterobacterales isolation was from chicken intestine with a frequency of 92/252 (36.5%). Generally, all the recovered Enterobacterales were resistant (100%) to tetracycline and erythromycin, except for Klebsiella spp in which 16.7% resistance frequency was observed. Resistances were also observed with ampicillin (37.5%-100%), gentamicin (34.4%-66.7%) and ciprofloxacin (12.5%-83.3%). The average multiple antibiotic resistance index (MARI) value of the recovered isolates in this study was 0.7. This study has shown that chicken viscera parts are contaminated by multidrug-resistant (MDR) Enterobacterales such as Shigella spp., E. coli, Klebsiella spp. and Salmonella spp.
- Open Access
- 7 August 2025
- Published by MDPI AG in Preprints.org
Gut Microbiome Dynamics and Their Emerging Role in Breast and Colorectal Cancer: Implications for Diagnosis and Therapy
The gut microbiome, a complex community of microorganisms residing in the gastrointestinal tract, is increasingly recognized as a critical player in cancer pathophysiology. Its influence extends beyond local gastrointestinal disorders to systemic diseases, including breast and colorectal cancers. This review examines current evidence on the interplay between gut microbial dysbiosis and the development, progression, and treatment response in both malignancies. In colorectal cancer (CRC), pathogenic bacteria such as Fusobacterium nucleatum, Escherichia coli, and Bacteroides fragilis have been implicated in tumor initiation and progression through mechanisms involving chronic inflammation, DNA damage, and immune modulation. Meanwhile, in breast cancer, the gut microbiome may contribute indirectly via regulation of estrogen metabolism, immune signaling, and systemic inflammation. Furthermore, the gut microbiota is increasingly being explored as a source of non-invasive biomarkers for early detection and disease monitoring, as well as a modifiable factor that could enhance therapeutic efficacy. Interventions such as probiotics, prebiotics, dietary modulation, and fecal microbiota transplantation (FMT) hold promise in reprogramming the microbiome to support antitumor responses and reduce treatment-related toxicity. Despite the growing body of research, translating these findings into clinical application requires deeper mechanistic understanding and standardized methodologies. This review emphasizes the need for longitudinal and multi-omics studies to unravel causal relationships and identify therapeutic targets. Understanding gut microbiome dynamics offers exciting opportunities for developing microbiota-informed strategies for cancer prevention, diagnosis, and therapy—particularly in breast and colorectal cancers.
- 7 August 2025
- Published by MDPI AG in Preprints.org
Open AccessGut Microbiome Dynamics and Their Emerging Role in Breast and Colorectal Cancer: Implications for Diagnosis and Therapy
The gut microbiome, a complex community of microorganisms residing in the gastrointestinal tract, is increasingly recognized as a critical player in cancer pathophysiology. Its influence extends beyond local gastrointestinal disorders to systemic diseases, including breast and colorectal cancers. This review examines current evidence on the interplay between gut microbial dysbiosis and the development, progression, and treatment response in both malignancies. In colorectal cancer (CRC), pathogenic bacteria such as Fusobacterium nucleatum, Escherichia coli, and Bacteroides fragilis have been implicated in tumor initiation and progression through mechanisms involving chronic inflammation, DNA damage, and immune modulation. Meanwhile, in breast cancer, the gut microbiome may contribute indirectly via regulation of estrogen metabolism, immune signaling, and systemic inflammation. Furthermore, the gut microbiota is increasingly being explored as a source of non-invasive biomarkers for early detection and disease monitoring, as well as a modifiable factor that could enhance therapeutic efficacy. Interventions such as probiotics, prebiotics, dietary modulation, and fecal microbiota transplantation (FMT) hold promise in reprogramming the microbiome to support antitumor responses and reduce treatment-related toxicity. Despite the growing body of research, translating these findings into clinical application requires deeper mechanistic understanding and standardized methodologies. This review emphasizes the need for longitudinal and multi-omics studies to unravel causal relationships and identify therapeutic targets. Understanding gut microbiome dynamics offers exciting opportunities for developing microbiota-informed strategies for cancer prevention, diagnosis, and therapy—particularly in breast and colorectal cancers.